Jason Carroll

Jason Carroll

Patrimonio netto: 9 M $ in data 31/07/2026

Consumer Services
Health Technology
Consumer Non-Durables

Profilo

Jason Carroll is currently Chief Executive Officer at Tryp Therapeutics, Inc. since 2023, Chief Executive Officer, Director & MD at Entropy Neurodynamics Ltd. since 2024, and Non-Executive Chairman at Island Pharmaceuticals Ltd. starting in 2025.
Formerly, Mr. Carroll was Managing Director at Inova Pharmaceuticals (Philippines), Inc. from 2017 to 2023,.
Managing Director at Johnson & Johnson (Vietnam) Co. Ltd. from 2014 to 2017, and General Manager at Janssen Pharmaceutica (Philippines) from 2012 to 2014.
Education includes undergraduate studies at Flinders University and an MBA from Deakin University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
03/12/2025 32.074.930 ( 10,84% ) 9 M $ 31/07/2026

Posizioni attive di Jason Carroll

SocietàPosizioneInizio
ISLAND PHARMACEUTICALS LIMITED Presidente 02/07/2025
Amministratore Delegato 01/10/2023

Precedenti posizioni note di Jason Carroll

SocietàPosizioneFine
Corporate Officer/Principal 01/03/2017
Vedi nel dettaglio l'esperienza di Jason Carroll

Formazione di Jason Carroll

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

20

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private5

Consumer Services

Consumer Services

Consumer Non-Durables

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Jason Carroll